Hermes Biosciences
hermesbio.com
Actively hiring
Bioprocessing
Cell & Gene Therapy
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Paladin Capital Group
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Paladin Capital Group Similar startupsby what they do, their industry and backers
Aegle Therapeutics is a pioneer in regenerative medicine developing extracellular vesicle (EV) therapy to meaningfully improve the lives of…
Patented ELAREM™ cell culture supplements: Human Platelet Lysate (HPL) xeno-free NEW: Artificial HPL PL BioScience.
Caladan Bio delivers automated high-throughput benchtop bioreactor systems for fermentation and cell culture teams.
Organ-on-a-chip supplier of the 1st human-derived hydrogel for 2D & 3D cell culture. Our fat-on-a-chip platform is a more accurate way to…
Cell sorters by NanoCellect, like the WOLF G2 microfluidic cell sorter, provide gentle sorting analysis for fragile cells. The VERLO cell…
At Frontier Space, we enable next-generation biotechnology R&D in orbit—providing microgravity platforms for protein crystallisation, cell…
Overview
Mercury Biosciences presents a benchtop, hands-off, extracellular vesicle isolation system that directly processes any bodily fluid and cell culture media to purify exosomes quickly, efficiently, and reproducibly.Finally, researchers can begin to understand exosome function and its use in clinical applications like oncology, degenerative disease and regenerative medicine.
News
Sağlık Bakanı Memişoğlu'ndan ABD'de Biyoteknoloji Çıkarması: Hermes Biosciences'a Ziyaret
Sağlık Bakanı Kemal Memişoğlu, ABD temasları kapsamında biyoteknoloji alanında çalışmalar yürüten Hermes Biosciences şirketini ziyaret ederek incelemelerde bulundu.
Read more
Report
Hermes Biosciences Raises Seed Funding to Make Extracellular Vesicles a Practical Tool for Precision Medicine
New technology captures the biological units of communication between cells at higher yield and quality, increasing their value in understanding, diagnosing, and treating cancer, degenerative diseases, and conditions in regenerative medicine.
Read more
Report
Hermes Biosciences: Seed Funding Raised To Advance High-Yield Extracellular Vesicle Isolation Technology
Hermes Biosciences has secured a seed financing round to advance the delivery of its first commercial benchtop instrument for isolating extracellular vesicles. The company plans to debut the platform in 2026 for clinical researchers in academia, pharmaceu
Read more
Report